dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Julia Cano, Antonio |
dc.contributor.author | Lopez Lasanta, Maria America |
dc.contributor.author | Blanco, Francisco |
dc.contributor.author | Gomez Moruno, Antonio |
dc.contributor.author | Haro, Isabel |
dc.contributor.author | Mas, Antonio Juan |
dc.contributor.author | Palau Balaña, Nuria |
dc.contributor.author | Lastra Borras, Raquel Maria |
dc.contributor.author | Llados Segura, Jordi Francesc |
dc.contributor.author | Marsal Barril, Sara |
dc.contributor.author | Erra Duran, Alba |
dc.date.accessioned | 2021-12-03T10:12:31Z |
dc.date.available | 2021-12-03T10:12:31Z |
dc.date.issued | 2021-04-21 |
dc.identifier.citation | Julià A, López-Lasanta M, Blanco F, Gómez A, Haro I, Mas AJ, et al. Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC Musculoskelet Disord. 2021 Apr 21;22:372. |
dc.identifier.issn | 1471-2474 |
dc.identifier.uri | https://hdl.handle.net/11351/6648 |
dc.description | Teràpia anti TNF; Autoanticossos; Artritis reumatoide |
dc.description.sponsorship | This project was supported by UCB Pharma. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | BMC Musculoskeletal Disorders;22 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Artritis reumatoide - Tractament |
dc.subject | Antiinflamatoris - Ús terapèutic |
dc.subject | Autoanticossos |
dc.subject.mesh | Arthritis, Rheumatoid |
dc.subject.mesh | Anti-Inflammatory Agents |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Rheumatoid Factor |
dc.title | Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12891-021-04248-y |
dc.subject.decs | artritis reumatoide |
dc.subject.decs | antiinflamatorios |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | factor reumatoide |
dc.relation.publishversion | https://doi.org/10.1186/s12891-021-04248-y |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Julià A, López-Lasanta M, Gómez A, Erra A, Palau N, Lastra R, Lladós J, Marsal S] Grup de Recerca en Reumatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Blanco F] Rheumatology Department, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain. [Haro I] Unitat de Síntesi i Aplicacions Biomèdiques de Pèptids, IQAC-CSIC, Barcelona, Spain. [Mas AJ] Rheumatology Department, Hospital Universitario Son Llàtzer, Mallorca, Spain |
dc.identifier.pmid | 33882889 |
dc.identifier.wos | 000642162800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |